News
The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally intervened to place restrictions on COVID shots from vaccine makers Novavax and ...
Currently, there are two Moderna COVID-19 vaccines available: SPIKEVAX and the 2024 – 2025 formula. Both vaccines contain similar ingredients. For example, the SPIKEVAX contains the following: ...
Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...
The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.
Findings showed mNexspike showed a 9.3% (99.4% CI, -6.6, 22.8) higher relative vaccine efficacy compared with Moderna’s original COVID-19 vaccine.
Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...
People 18 and older who got their primary COVID-19 vaccine shots or their most recent booster shots at least two months ago are eligible to receive a single dose of the new Moderna booster ...
The U.S. government considers you fully vaccinated if you’ve received two primary vaccine doses and one of the updated booster shots, such as the 2024–2025 COVID-19 vaccine.
The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to 59 years old who are at increased risk for severe illness from ...
Pharmalittle: We’re reading about Merck eyeing a biotech, a Moderna Covid vaccine trial, and more FDA Commissioner Marty Makary committed to reviewing the abortion drug mifepristone Alex Hogan/STAT ...
Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results